Related Experiment Video
Updated: Apr 23, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Mycoplasma pneumoniae infections--does treatment help?
Emiel B M Spuesens1, Patrick M Meyer Sauteur1, Cornelis Vink2
1Department of Pediatrics, Division of Infectious Diseases and Immunology, Erasmus University Medical Center-Sophia Children's Hospital, PO Box 2040, 3000 CA Rotterdam, The Netherlands.
Mycoplasma pneumoniae infections in children are common, but diagnosis is complicated by asymptomatic carriage. Antibiotic treatment efficacy is uncertain, and macrolide resistance is rising, necessitating a reevaluation of current practices.
Area of Science:
- Pediatric Infectious Diseases
- Respiratory Medicine
- Microbiology
Background:
- Mycoplasma pneumoniae is a frequent cause of pediatric respiratory tract infections (RTIs).
- Asymptomatic carriage of M. pneumoniae in healthy children complicates diagnosis and treatment decisions.
- Current antibiotic treatment guidelines for M. pneumoniae RTIs lack robust evidence.
Purpose of the Study:
- To review current challenges in diagnosing M. pneumoniae infections in children.
- To evaluate the available evidence on antibiotic efficacy for M. pneumoniae RTIs.
- To discuss emerging issues, including antibiotic resistance and potential adjunctive therapies.
Main Methods:
- Review of existing literature and clinical findings.
- Analysis of data regarding M. pneumoniae carriage in asymptomatic children.
- Assessment of antibiotic efficacy studies and systematic reviews.
Main Results:
- M. pneumoniae is commonly found in asymptomatic children, complicating diagnosis.
- Evidence for antibiotic treatment efficacy in pediatric M. pneumoniae lower respiratory tract infections (LRTI) is insufficient.
- Increasing macrolide resistance threatens current treatment options for M. pneumoniae infections.
Conclusions:
- Diagnosis and treatment strategies for M. pneumoniae infections require reconsideration.
- Limited evidence supports antibiotic use, and macrolide resistance is a growing concern.
- Further research is needed to establish effective treatment protocols and explore alternative therapies like corticosteroids.
Related Concept Videos
Atypical Pneumonia
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
COPD: Management Using Bronchodilators and Corticosteroids
Acute Pyelonephritis II: Diagnostic Studies and Management
